Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of neurotransmitter secretion (GO:0046929) | 8.42781700 |
2 | positive regulation of amino acid transport (GO:0051957) | 8.13597048 |
3 | positive regulation of catecholamine secretion (GO:0033605) | 8.10398368 |
4 | negative regulation of amino acid transport (GO:0051956) | 7.83228163 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.16430106 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.16430106 |
7 | L-phenylalanine metabolic process (GO:0006558) | 6.95140115 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.95140115 |
9 | serotonin receptor signaling pathway (GO:0007210) | 6.38427930 |
10 | negative regulation of neurotransmitter transport (GO:0051589) | 6.34260532 |
11 | aromatic amino acid family catabolic process (GO:0009074) | 6.21896131 |
12 | phospholipid scrambling (GO:0017121) | 6.21707457 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.94490714 |
14 | regulation of glutamate secretion (GO:0014048) | 5.91325674 |
15 | glyoxylate metabolic process (GO:0046487) | 5.67897549 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52520830 |
17 | kynurenine metabolic process (GO:0070189) | 5.43402019 |
18 | indole-containing compound catabolic process (GO:0042436) | 5.40159279 |
19 | indolalkylamine catabolic process (GO:0046218) | 5.40159279 |
20 | tryptophan catabolic process (GO:0006569) | 5.40159279 |
21 | cysteine metabolic process (GO:0006534) | 5.38166098 |
22 | bile acid biosynthetic process (GO:0006699) | 5.35839737 |
23 | sulfur amino acid catabolic process (GO:0000098) | 5.35652577 |
24 | lysine catabolic process (GO:0006554) | 5.12571912 |
25 | lysine metabolic process (GO:0006553) | 5.12571912 |
26 | tryptophan metabolic process (GO:0006568) | 5.08286771 |
27 | urea cycle (GO:0000050) | 5.02774529 |
28 | urea metabolic process (GO:0019627) | 5.02774529 |
29 | serine family amino acid catabolic process (GO:0009071) | 5.02591125 |
30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.99315169 |
31 | cullin deneddylation (GO:0010388) | 4.93997226 |
32 | negative regulation of fibrinolysis (GO:0051918) | 4.92780398 |
33 | regulation of triglyceride catabolic process (GO:0010896) | 4.82956864 |
34 | protein carboxylation (GO:0018214) | 4.82260399 |
35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.82260399 |
36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80441499 |
37 | complement activation, alternative pathway (GO:0006957) | 4.77402535 |
38 | pharyngeal system development (GO:0060037) | 4.75545689 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.68890566 |
40 | regulation of protein activation cascade (GO:2000257) | 4.68779293 |
41 | nitrogen cycle metabolic process (GO:0071941) | 4.68476315 |
42 | regulation of fibrinolysis (GO:0051917) | 4.68435170 |
43 | alpha-amino acid catabolic process (GO:1901606) | 4.60274897 |
44 | homocysteine metabolic process (GO:0050667) | 4.57438338 |
45 | bile acid metabolic process (GO:0008206) | 4.57043069 |
46 | aromatic amino acid family metabolic process (GO:0009072) | 4.56040152 |
47 | acylglycerol homeostasis (GO:0055090) | 4.53764439 |
48 | triglyceride homeostasis (GO:0070328) | 4.53764439 |
49 | cellular ketone body metabolic process (GO:0046950) | 4.52965198 |
50 | glycine metabolic process (GO:0006544) | 4.48772628 |
51 | protein deneddylation (GO:0000338) | 4.43806824 |
52 | reverse cholesterol transport (GO:0043691) | 4.40364401 |
53 | regulation of dopamine secretion (GO:0014059) | 4.38487641 |
54 | regulation of complement activation (GO:0030449) | 4.37990735 |
55 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33978093 |
56 | protein-lipid complex remodeling (GO:0034368) | 4.33978093 |
57 | macromolecular complex remodeling (GO:0034367) | 4.33978093 |
58 | plasma lipoprotein particle clearance (GO:0034381) | 4.33708077 |
59 | * cellular amino acid catabolic process (GO:0009063) | 4.32667503 |
60 | DNA replication checkpoint (GO:0000076) | 4.32213573 |
61 | tyrosine metabolic process (GO:0006570) | 4.29996646 |
62 | serine family amino acid metabolic process (GO:0009069) | 4.29948132 |
63 | regulation of cholesterol esterification (GO:0010872) | 4.25758822 |
64 | fatty acid beta-oxidation (GO:0006635) | 4.24061428 |
65 | acetyl-CoA metabolic process (GO:0006084) | 4.23621069 |
66 | serine family amino acid biosynthetic process (GO:0009070) | 4.22775133 |
67 | coenzyme catabolic process (GO:0009109) | 4.20917437 |
68 | short-chain fatty acid metabolic process (GO:0046459) | 4.19747120 |
69 | ethanol oxidation (GO:0006069) | 4.14525022 |
70 | 2-oxoglutarate metabolic process (GO:0006103) | 4.08645493 |
71 | negative regulation of sterol transport (GO:0032372) | 4.08161055 |
72 | negative regulation of cholesterol transport (GO:0032375) | 4.08161055 |
73 | fatty acid oxidation (GO:0019395) | 4.08021119 |
74 | aspartate family amino acid catabolic process (GO:0009068) | 4.05149296 |
75 | valine metabolic process (GO:0006573) | 4.01563896 |
76 | lipid oxidation (GO:0034440) | 4.00402484 |
77 | positive regulation of organic acid transport (GO:0032892) | 4.00217722 |
78 | cellular modified amino acid catabolic process (GO:0042219) | 3.98841274 |
79 | glutamate metabolic process (GO:0006536) | 3.98826725 |
80 | fatty acid catabolic process (GO:0009062) | 3.98293925 |
81 | * carboxylic acid catabolic process (GO:0046395) | 3.97394952 |
82 | * organic acid catabolic process (GO:0016054) | 3.97394952 |
83 | muscle cell fate commitment (GO:0042693) | 3.95087700 |
84 | regulation of amino acid transport (GO:0051955) | 3.94969573 |
85 | monocarboxylic acid catabolic process (GO:0072329) | 3.92082032 |
86 | ketone body metabolic process (GO:1902224) | 3.91258950 |
87 | phospholipid efflux (GO:0033700) | 3.90308546 |
88 | * branched-chain amino acid catabolic process (GO:0009083) | 3.85870168 |
89 | imidazole-containing compound metabolic process (GO:0052803) | 3.85335577 |
90 | cellular glucuronidation (GO:0052695) | 3.83442373 |
91 | phenylpropanoid metabolic process (GO:0009698) | 3.83410093 |
92 | mannose metabolic process (GO:0006013) | 3.78332796 |
93 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.78057120 |
94 | indolalkylamine metabolic process (GO:0006586) | 3.76512352 |
95 | positive regulation of lipid catabolic process (GO:0050996) | 3.75586310 |
96 | cellular biogenic amine catabolic process (GO:0042402) | 3.73598128 |
97 | amine catabolic process (GO:0009310) | 3.73598128 |
98 | bile acid and bile salt transport (GO:0015721) | 3.70942478 |
99 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70826808 |
100 | carnitine metabolic process (GO:0009437) | 3.70406800 |
101 | intestinal epithelial cell development (GO:0060576) | 3.69933790 |
102 | aldehyde catabolic process (GO:0046185) | 3.69931590 |
103 | positive regulation of amine transport (GO:0051954) | 3.68417754 |
104 | benzene-containing compound metabolic process (GO:0042537) | 3.67886546 |
105 | biotin metabolic process (GO:0006768) | 3.65389062 |
106 | cholesterol efflux (GO:0033344) | 3.63127655 |
107 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.61133361 |
108 | negative regulation of lipase activity (GO:0060192) | 3.60353825 |
109 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.59690898 |
110 | arginine metabolic process (GO:0006525) | 3.59166701 |
111 | uronic acid metabolic process (GO:0006063) | 3.55691555 |
112 | glucuronate metabolic process (GO:0019585) | 3.55691555 |
113 | base-excision repair, AP site formation (GO:0006285) | 3.54911062 |
114 | N-glycan processing (GO:0006491) | 3.53632739 |
115 | * branched-chain amino acid metabolic process (GO:0009081) | 3.53075086 |
116 | fatty acid transmembrane transport (GO:1902001) | 3.51290738 |
117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50501608 |
118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50501608 |
119 | phospholipid homeostasis (GO:0055091) | 3.48347346 |
120 | L-serine metabolic process (GO:0006563) | 3.47987253 |
121 | cholesterol homeostasis (GO:0042632) | 3.46917781 |
122 | plasma lipoprotein particle assembly (GO:0034377) | 3.45012978 |
123 | low-density lipoprotein particle remodeling (GO:0034374) | 3.43780928 |
124 | cofactor catabolic process (GO:0051187) | 3.43242880 |
125 | regulation of cholesterol metabolic process (GO:0090181) | 3.42538226 |
126 | regulation of cardioblast proliferation (GO:0003264) | 3.32753627 |
127 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.32753627 |
128 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.28012355 |
129 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.16995637 |
130 | negative regulation of organic acid transport (GO:0032891) | 3.15650389 |
131 | negative regulation of amine transport (GO:0051953) | 3.12717453 |
132 | outer ear morphogenesis (GO:0042473) | 3.09831785 |
133 | S-adenosylmethionine metabolic process (GO:0046500) | 3.03983470 |
134 | regulation of membrane lipid distribution (GO:0097035) | 3.03133485 |
135 | exogenous drug catabolic process (GO:0042738) | 3.03096664 |
136 | proteasome assembly (GO:0043248) | 2.99888893 |
137 | somite development (GO:0061053) | 2.97914406 |
138 | urogenital system development (GO:0001655) | 2.89124702 |
139 | drug catabolic process (GO:0042737) | 2.85920243 |
140 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.84841882 |
141 | ribosome assembly (GO:0042255) | 2.84796835 |
142 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.83589720 |
143 | otic vesicle formation (GO:0030916) | 2.83365553 |
144 | protein complex biogenesis (GO:0070271) | 2.81347285 |
145 | flavonoid metabolic process (GO:0009812) | 2.79452636 |
146 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.76590823 |
147 | L-methionine salvage (GO:0071267) | 2.74026840 |
148 | L-methionine biosynthetic process (GO:0071265) | 2.74026840 |
149 | amino acid salvage (GO:0043102) | 2.74026840 |
150 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.73448264 |
151 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.73448264 |
152 | NADH dehydrogenase complex assembly (GO:0010257) | 2.73448264 |
153 | DNA deamination (GO:0045006) | 2.71350881 |
154 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.70055606 |
155 | drug metabolic process (GO:0017144) | 2.69689955 |
156 | protein K11-linked ubiquitination (GO:0070979) | 2.69074948 |
157 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.65044988 |
158 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.58249007 |
159 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.54106796 |
160 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.54106796 |
161 | cytidine deamination (GO:0009972) | 2.54042197 |
162 | cytidine metabolic process (GO:0046087) | 2.54042197 |
163 | cytidine catabolic process (GO:0006216) | 2.54042197 |
164 | epithelial cilium movement (GO:0003351) | 2.52795114 |
165 | aggressive behavior (GO:0002118) | 2.52773964 |
166 | formation of translation preinitiation complex (GO:0001731) | 2.51972751 |
167 | behavioral response to nicotine (GO:0035095) | 2.50151622 |
168 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.49322001 |
169 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.44219432 |
170 | regulation of action potential (GO:0098900) | 2.42231990 |
171 | thalamus development (GO:0021794) | 2.40973148 |
172 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.40220918 |
173 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.39942084 |
174 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.39536038 |
175 | atrial septum morphogenesis (GO:0060413) | 2.39023239 |
176 | chaperone-mediated protein transport (GO:0072321) | 2.37028482 |
177 | meiotic chromosome segregation (GO:0045132) | 2.34460374 |
178 | cellular response to sterol (GO:0036315) | 2.33807535 |
179 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.32460508 |
180 | oxidative demethylation (GO:0070989) | 2.32082479 |
181 | early endosome to late endosome transport (GO:0045022) | 2.31895859 |
182 | epithelial cell fate commitment (GO:0072148) | 2.31120118 |
183 | intraciliary transport (GO:0042073) | 2.29893555 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.93645640 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.24778080 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.87275323 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.11020076 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.08518752 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.98971684 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86286511 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81177426 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.69230762 |
10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.59515481 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.36288380 |
12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.30807271 |
13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.86835965 |
14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.77229507 |
15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.76169697 |
16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.71198194 |
17 | EWS_26573619_Chip-Seq_HEK293_Human | 2.70277999 |
18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.66315852 |
19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.64649332 |
20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.43008531 |
21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34547917 |
22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30056648 |
23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18469894 |
24 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.17462096 |
25 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15491026 |
26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14268142 |
27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.08761566 |
28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04182476 |
29 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.02284120 |
30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01185282 |
31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3847851 |
32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97181085 |
33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96763528 |
34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93375448 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82685069 |
36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.75919431 |
37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73816926 |
38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71278277 |
39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.70034248 |
40 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62938051 |
41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.62930840 |
42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62920917 |
43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60286681 |
44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59474080 |
45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58492772 |
46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58364510 |
47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57678625 |
48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55710008 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54905086 |
50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.54875342 |
51 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54779646 |
52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53399301 |
53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.52988608 |
54 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.52608523 |
55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52395360 |
56 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49128099 |
57 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49011751 |
58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45911257 |
59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44629558 |
60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44441460 |
61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.44181210 |
62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.42720139 |
63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41885202 |
64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41714784 |
65 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.41538468 |
66 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40776366 |
67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39782670 |
68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38911787 |
69 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36901582 |
70 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36901582 |
71 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.35998334 |
72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35383320 |
73 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.33697662 |
74 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33443971 |
75 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31781193 |
76 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.31541844 |
77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29873861 |
78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29847966 |
79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29326167 |
80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28586020 |
81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26846003 |
82 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25890502 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25771175 |
84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25706147 |
85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25267201 |
86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24565851 |
87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24316181 |
88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24316181 |
89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23490998 |
90 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22256734 |
91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22047539 |
92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21024690 |
93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18289256 |
94 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18149975 |
95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17738200 |
96 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.16970842 |
97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16061064 |
98 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15796654 |
99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15494227 |
100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12678102 |
101 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10880090 |
102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10099994 |
103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10039554 |
104 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09929921 |
105 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09929921 |
106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09650857 |
107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09145032 |
108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08656588 |
109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08262366 |
110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08218955 |
111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07856510 |
112 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07423546 |
113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06070599 |
114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06034224 |
115 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05002075 |
116 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04763372 |
117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04346892 |
118 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.03906861 |
119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03679399 |
120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03059172 |
121 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02597824 |
122 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01252598 |
123 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.00160874 |
124 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99980056 |
125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99440999 |
126 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98700449 |
127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97489528 |
128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92757062 |
129 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91155557 |
130 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91076329 |
131 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86992491 |
132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83419059 |
133 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.82575372 |
134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80166789 |
135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74125112 |
136 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74094519 |
137 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73320810 |
138 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71215226 |
139 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70594706 |
140 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70434438 |
141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65010675 |
142 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.64798242 |
143 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64180088 |
144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62285107 |
145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62259982 |
146 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61985372 |
147 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.61121767 |
148 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.59545457 |
149 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.58827659 |
150 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58320766 |
151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.57796548 |
152 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55197387 |
153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55122696 |
154 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53705843 |
155 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51792046 |
156 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.51051724 |
157 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.50850583 |
158 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.50313622 |
159 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.50027170 |
160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49976915 |
161 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49541441 |
162 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.48891735 |
163 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.47339094 |
164 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.47121294 |
165 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.47041683 |
166 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46532360 |
167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.46307539 |
168 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.46307539 |
169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45584993 |
170 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45111436 |
171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45007814 |
172 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.44452813 |
173 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.44401019 |
174 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.44344297 |
175 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.44344297 |
176 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44268710 |
177 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44244877 |
178 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.44220763 |
179 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.43678287 |
180 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43486752 |
181 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43291420 |
182 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42374240 |
183 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.40789367 |
184 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.39466518 |
185 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.39305146 |
186 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.38799255 |
187 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.38489947 |
188 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37710404 |
189 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37104613 |
190 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.36437131 |
191 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.36373411 |
192 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36146551 |
193 | ATF3_27146783_Chip-Seq_COLON_Human | 0.35962518 |
194 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.35630159 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.70147498 |
2 | MP0005360_urolithiasis | 6.90600177 |
3 | MP0005365_abnormal_bile_salt | 5.99098611 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.97691627 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69009740 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.67714399 |
7 | MP0008961_abnormal_basal_metabolism | 4.56278374 |
8 | MP0002822_catalepsy | 4.35542258 |
9 | MP0002234_abnormal_pharynx_morphology | 3.89075186 |
10 | MP0010329_abnormal_lipoprotein_level | 3.58011082 |
11 | MP0003252_abnormal_bile_duct | 3.37640512 |
12 | MP0009840_abnormal_foam_cell | 3.07800471 |
13 | MP0005332_abnormal_amino_acid | 2.98758773 |
14 | MP0005083_abnormal_biliary_tract | 2.96197394 |
15 | MP0003195_calcinosis | 2.76938572 |
16 | MP0001666_abnormal_nutrient_absorption | 2.56945365 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.31087118 |
18 | MP0001529_abnormal_vocalization | 2.29558920 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.29427196 |
20 | MP0002102_abnormal_ear_morphology | 2.28914565 |
21 | MP0006292_abnormal_olfactory_placode | 2.25062545 |
22 | MP0005670_abnormal_white_adipose | 2.14994385 |
23 | MP0000609_abnormal_liver_physiology | 2.13577041 |
24 | MP0003136_yellow_coat_color | 1.96306821 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.94593075 |
26 | MP0008058_abnormal_DNA_repair | 1.94455254 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.91311969 |
28 | MP0004215_abnormal_myocardial_fiber | 1.90843882 |
29 | MP0000049_abnormal_middle_ear | 1.81918648 |
30 | MP0002735_abnormal_chemical_nociception | 1.70020470 |
31 | MP0002396_abnormal_hematopoietic_system | 1.68587273 |
32 | MP0003868_abnormal_feces_composition | 1.67485674 |
33 | MP0003186_abnormal_redox_activity | 1.66871826 |
34 | MP0001764_abnormal_homeostasis | 1.65693342 |
35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64804906 |
36 | MP0004130_abnormal_muscle_cell | 1.64765688 |
37 | MP0003937_abnormal_limbs/digits/tail_de | 1.60192769 |
38 | MP0008877_abnormal_DNA_methylation | 1.59637263 |
39 | MP0005551_abnormal_eye_electrophysiolog | 1.58841989 |
40 | MP0006036_abnormal_mitochondrial_physio | 1.58222440 |
41 | MP0002837_dystrophic_cardiac_calcinosis | 1.53776607 |
42 | MP0002938_white_spotting | 1.50320823 |
43 | MP0002138_abnormal_hepatobiliary_system | 1.45977785 |
44 | MP0009697_abnormal_copulation | 1.43010588 |
45 | MP0000372_irregular_coat_pigmentation | 1.42567168 |
46 | MP0003119_abnormal_digestive_system | 1.42459811 |
47 | MP0009643_abnormal_urine_homeostasis | 1.40449200 |
48 | MP0005666_abnormal_adipose_tissue | 1.40276981 |
49 | MP0005253_abnormal_eye_physiology | 1.36554774 |
50 | MP0006072_abnormal_retinal_apoptosis | 1.35102094 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.33353454 |
52 | MP0006054_spinal_hemorrhage | 1.31819920 |
53 | MP0005646_abnormal_pituitary_gland | 1.31700158 |
54 | MP0003122_maternal_imprinting | 1.31550312 |
55 | MP0003705_abnormal_hypodermis_morpholog | 1.31410430 |
56 | MP0005451_abnormal_body_composition | 1.30693688 |
57 | MP0004142_abnormal_muscle_tone | 1.30574301 |
58 | MP0000566_synostosis | 1.29866368 |
59 | MP0009745_abnormal_behavioral_response | 1.29710029 |
60 | MP0010094_abnormal_chromosome_stability | 1.29258870 |
61 | MP0001293_anophthalmia | 1.29156892 |
62 | MP0000613_abnormal_salivary_gland | 1.27281418 |
63 | MP0000631_abnormal_neuroendocrine_gland | 1.24894344 |
64 | MP0002233_abnormal_nose_morphology | 1.24150103 |
65 | MP0003283_abnormal_digestive_organ | 1.23566737 |
66 | MP0002971_abnormal_brown_adipose | 1.23288653 |
67 | MP0003011_delayed_dark_adaptation | 1.21775650 |
68 | MP0003880_abnormal_central_pattern | 1.19723714 |
69 | MP0004484_altered_response_of | 1.19180457 |
70 | MP0001984_abnormal_olfaction | 1.15167782 |
71 | MP0000598_abnormal_liver_morphology | 1.15146099 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.14661143 |
73 | MP0003938_abnormal_ear_development | 1.14214943 |
74 | MP0005167_abnormal_blood-brain_barrier | 1.14088889 |
75 | MP0005647_abnormal_sex_gland | 1.10898105 |
76 | MP0001485_abnormal_pinna_reflex | 1.10090597 |
77 | MP0003121_genomic_imprinting | 1.09625528 |
78 | MP0002078_abnormal_glucose_homeostasis | 1.04282512 |
79 | MP0008995_early_reproductive_senescence | 1.02646893 |
80 | MP0010030_abnormal_orbit_morphology | 1.02360530 |
81 | MP0001661_extended_life_span | 1.00194257 |
82 | MP0005535_abnormal_body_temperature | 1.00086400 |
83 | MP0006035_abnormal_mitochondrial_morpho | 0.99944062 |
84 | MP0002638_abnormal_pupillary_reflex | 0.98404679 |
85 | MP0002249_abnormal_larynx_morphology | 0.98119028 |
86 | MP0003786_premature_aging | 0.97615201 |
87 | MP0005266_abnormal_metabolism | 0.97399478 |
88 | MP0001963_abnormal_hearing_physiology | 0.96815388 |
89 | MP0004185_abnormal_adipocyte_glucose | 0.96796063 |
90 | MP0002163_abnormal_gland_morphology | 0.96642483 |
91 | MP0000604_amyloidosis | 0.96239474 |
92 | MP0009763_increased_sensitivity_to | 0.95864840 |
93 | MP0005334_abnormal_fat_pad | 0.95317319 |
94 | MP0005379_endocrine/exocrine_gland_phen | 0.92960199 |
95 | MP0002876_abnormal_thyroid_physiology | 0.91905598 |
96 | MP0003646_muscle_fatigue | 0.91735276 |
97 | MP0002736_abnormal_nociception_after | 0.91572434 |
98 | MP0010368_abnormal_lymphatic_system | 0.91268059 |
99 | MP0005636_abnormal_mineral_homeostasis | 0.90906920 |
100 | MP0002282_abnormal_trachea_morphology | 0.89765623 |
101 | MP0008932_abnormal_embryonic_tissue | 0.88872302 |
102 | MP0001486_abnormal_startle_reflex | 0.88859703 |
103 | MP0006276_abnormal_autonomic_nervous | 0.88751833 |
104 | MP0005376_homeostasis/metabolism_phenot | 0.88131384 |
105 | MP0008789_abnormal_olfactory_epithelium | 0.87531336 |
106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86248627 |
107 | MP0005220_abnormal_exocrine_pancreas | 0.86061012 |
108 | MP0009642_abnormal_blood_homeostasis | 0.84701520 |
109 | MP0002254_reproductive_system_inflammat | 0.84102768 |
110 | MP0009250_abnormal_appendicular_skeleto | 0.83409614 |
111 | MP0005389_reproductive_system_phenotype | 0.82464894 |
112 | MP0004885_abnormal_endolymph | 0.81800376 |
113 | MP0002272_abnormal_nervous_system | 0.81229443 |
114 | MP0005084_abnormal_gallbladder_morpholo | 0.80231682 |
115 | MP0003137_abnormal_impulse_conducting | 0.79769941 |
116 | MP0005187_abnormal_penis_morphology | 0.79466257 |
117 | MP0002160_abnormal_reproductive_system | 0.79395945 |
118 | MP0001756_abnormal_urination | 0.78392244 |
119 | MP0000026_abnormal_inner_ear | 0.77902622 |
120 | MP0004924_abnormal_behavior | 0.77886058 |
121 | MP0005386_behavior/neurological_phenoty | 0.77886058 |
122 | MP0005448_abnormal_energy_balance | 0.77477189 |
123 | MP0004043_abnormal_pH_regulation | 0.76068231 |
124 | MP0003329_amyloid_beta_deposits | 0.75965581 |
125 | MP0005330_cardiomyopathy | 0.73624863 |
126 | MP0002557_abnormal_social/conspecific_i | 0.73504160 |
127 | MP0005375_adipose_tissue_phenotype | 0.73408556 |
128 | MP0004957_abnormal_blastocyst_morpholog | 0.73011219 |
129 | MP0009764_decreased_sensitivity_to | 0.72672364 |
130 | MP0003690_abnormal_glial_cell | 0.71744430 |
131 | MP0005195_abnormal_posterior_eye | 0.70585032 |
132 | MP0008469_abnormal_protein_level | 0.70318578 |
133 | MP0003755_abnormal_palate_morphology | 0.68981256 |
134 | MP0004133_heterotaxia | 0.68275923 |
135 | MP0001664_abnormal_digestion | 0.67792105 |
136 | MP0009765_abnormal_xenobiotic_induced | 0.67206197 |
137 | MP0001968_abnormal_touch/_nociception | 0.67173933 |
138 | MP0002751_abnormal_autonomic_nervous | 0.66841845 |
139 | MP0002970_abnormal_white_adipose | 0.65006228 |
140 | MP0009115_abnormal_fat_cell | 0.64952244 |
141 | MP0002269_muscular_atrophy | 0.63108411 |
142 | MP0005408_hypopigmentation | 0.62208945 |
143 | MP0003953_abnormal_hormone_level | 0.54567782 |
144 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50804222 |
145 | MP0009672_abnormal_birth_weight | 0.49597964 |
146 | MP0003718_maternal_effect | 0.47492297 |
147 | MP0000230_abnormal_systemic_arterial | 0.47292873 |
148 | MP0005395_other_phenotype | 0.47188413 |
149 | MP0002332_abnormal_exercise_endurance | 0.46812800 |
150 | MP0003959_abnormal_lean_body | 0.46732204 |
151 | MP0002136_abnormal_kidney_physiology | 0.46389071 |
152 | MP0000639_abnormal_adrenal_gland | 0.45160967 |
153 | MP0009053_abnormal_anal_canal | 0.44823428 |
154 | MP0002796_impaired_skin_barrier | 0.43787874 |
155 | MP0004036_abnormal_muscle_relaxation | 0.41633280 |
156 | MP0005452_abnormal_adipose_tissue | 0.41570556 |
157 | MP0006138_congestive_heart_failure | 0.38900525 |
158 | MP0003638_abnormal_response/metabolism_ | 0.38838373 |
159 | MP0001544_abnormal_cardiovascular_syste | 0.36404438 |
160 | MP0005385_cardiovascular_system_phenoty | 0.36404438 |
161 | MP0004147_increased_porphyrin_level | 0.35404650 |
162 | MP0008873_increased_physiological_sensi | 0.35167479 |
163 | MP0008872_abnormal_physiological_respon | 0.34689842 |
164 | MP0008874_decreased_physiological_sensi | 0.31838152 |
165 | MP0008775_abnormal_heart_ventricle | 0.29163939 |
166 | MP0004087_abnormal_muscle_fiber | 0.28856787 |
167 | MP0002168_other_aberrant_phenotype | 0.27890164 |
168 | MP0001944_abnormal_pancreas_morphology | 0.27316845 |
169 | MP0005248_abnormal_Harderian_gland | 0.26578758 |
170 | MP0002090_abnormal_vision | 0.26459633 |
171 | MP0000747_muscle_weakness | 0.26455497 |
172 | MP0005058_abnormal_lysosome_morphology | 0.26299227 |
173 | MP0004782_abnormal_surfactant_physiolog | 0.25792937 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.76923728 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.33605813 |
3 | Deep venous thrombosis (HP:0002625) | 6.25740174 |
4 | Xanthomatosis (HP:0000991) | 5.74048244 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.62945905 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.53492757 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.40276655 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.33547968 |
9 | Hyperglycinemia (HP:0002154) | 5.04972677 |
10 | Hyperglycinuria (HP:0003108) | 5.02134227 |
11 | Hyperammonemia (HP:0001987) | 5.02064292 |
12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.85750405 |
13 | Abnormality of glycine metabolism (HP:0010895) | 4.85750405 |
14 | Hypoglycemic coma (HP:0001325) | 4.77549286 |
15 | * Ketosis (HP:0001946) | 4.71490724 |
16 | Complement deficiency (HP:0004431) | 4.56720202 |
17 | Hypolipoproteinemia (HP:0010981) | 4.48352994 |
18 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.29372539 |
19 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 4.28203678 |
20 | Short 1st metacarpal (HP:0010034) | 4.28203678 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20753547 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 4.18145096 |
23 | Abnormality of the renal collecting system (HP:0004742) | 4.11289870 |
24 | Ketoacidosis (HP:0001993) | 3.95928561 |
25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.95118879 |
26 | Epidermoid cyst (HP:0200040) | 3.93682955 |
27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86340680 |
28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84133401 |
29 | Abnormality of the 1st metacarpal (HP:0010009) | 3.83746469 |
30 | Abnormality of methionine metabolism (HP:0010901) | 3.83284752 |
31 | Lipid accumulation in hepatocytes (HP:0006561) | 3.81716244 |
32 | Increased hepatocellular lipid droplets (HP:0006565) | 3.80784109 |
33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77293807 |
34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.74514616 |
35 | Joint hemorrhage (HP:0005261) | 3.72411701 |
36 | Fat malabsorption (HP:0002630) | 3.64229066 |
37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.56032274 |
38 | Dicarboxylic aciduria (HP:0003215) | 3.56032274 |
39 | Abnormality of serum amino acid levels (HP:0003112) | 3.51692317 |
40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41317836 |
41 | Delayed CNS myelination (HP:0002188) | 3.26897617 |
42 | Stenosis of the external auditory canal (HP:0000402) | 3.26359756 |
43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.24529172 |
44 | Hypercholesterolemia (HP:0003124) | 3.21845938 |
45 | Abnormality of complement system (HP:0005339) | 3.21308360 |
46 | Pancreatic fibrosis (HP:0100732) | 3.18757755 |
47 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.16346804 |
48 | * Lethargy (HP:0001254) | 3.14722334 |
49 | * Cerebral edema (HP:0002181) | 3.05525815 |
50 | Metabolic acidosis (HP:0001942) | 3.05207532 |
51 | True hermaphroditism (HP:0010459) | 3.02953372 |
52 | Medial flaring of the eyebrow (HP:0010747) | 3.01780463 |
53 | Generalized aminoaciduria (HP:0002909) | 2.98063047 |
54 | Renal Fanconi syndrome (HP:0001994) | 2.95024971 |
55 | Pancreatic cysts (HP:0001737) | 2.94184519 |
56 | Hyperbilirubinemia (HP:0002904) | 2.92474766 |
57 | Vertebral hypoplasia (HP:0008417) | 2.92459331 |
58 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.92459331 |
59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90997481 |
60 | Short phalanx of the thumb (HP:0009660) | 2.86740023 |
61 | Steatorrhea (HP:0002570) | 2.86670433 |
62 | Gout (HP:0001997) | 2.78341115 |
63 | Abnormality of purine metabolism (HP:0004352) | 2.78322820 |
64 | Methylmalonic acidemia (HP:0002912) | 2.78251147 |
65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.77833403 |
66 | Short hallux (HP:0010109) | 2.69466360 |
67 | Hypoglycemic seizures (HP:0002173) | 2.66790793 |
68 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.65896693 |
69 | Mitochondrial inheritance (HP:0001427) | 2.65803239 |
70 | Skin nodule (HP:0200036) | 2.65079670 |
71 | Attenuation of retinal blood vessels (HP:0007843) | 2.64738470 |
72 | Hepatocellular carcinoma (HP:0001402) | 2.64028674 |
73 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.56471311 |
74 | Molar tooth sign on MRI (HP:0002419) | 2.54349886 |
75 | Abnormality of midbrain morphology (HP:0002418) | 2.54349886 |
76 | Optic disc pallor (HP:0000543) | 2.53246567 |
77 | Myoglobinuria (HP:0002913) | 2.51592375 |
78 | Congenital stationary night blindness (HP:0007642) | 2.51176961 |
79 | * Vomiting (HP:0002013) | 2.47750438 |
80 | Large for gestational age (HP:0001520) | 2.46303539 |
81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.45597241 |
82 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.43577179 |
83 | Myocardial infarction (HP:0001658) | 2.43036853 |
84 | Spontaneous abortion (HP:0005268) | 2.41610532 |
85 | Spastic diplegia (HP:0001264) | 2.39706901 |
86 | Hepatic necrosis (HP:0002605) | 2.38496801 |
87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.36849518 |
88 | Irritability (HP:0000737) | 2.35293529 |
89 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.34141607 |
90 | Absent/shortened dynein arms (HP:0200106) | 2.34141607 |
91 | Abnormal gallbladder morphology (HP:0012437) | 2.33446751 |
92 | Duplicated collecting system (HP:0000081) | 2.33184801 |
93 | Hepatocellular necrosis (HP:0001404) | 2.32310066 |
94 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32226229 |
95 | Abnormality of alanine metabolism (HP:0010916) | 2.32226229 |
96 | Hyperalaninemia (HP:0003348) | 2.32226229 |
97 | Cholelithiasis (HP:0001081) | 2.30562331 |
98 | Brushfield spots (HP:0001088) | 2.29840362 |
99 | Proximal tubulopathy (HP:0000114) | 2.28750612 |
100 | Nausea (HP:0002018) | 2.28657446 |
101 | Hypochromic microcytic anemia (HP:0004840) | 2.25713783 |
102 | Increased CSF lactate (HP:0002490) | 2.24955718 |
103 | Neonatal onset (HP:0003623) | 2.23451320 |
104 | Acute encephalopathy (HP:0006846) | 2.23364066 |
105 | Nephronophthisis (HP:0000090) | 2.22857634 |
106 | Abnormality of cochlea (HP:0000375) | 2.20827884 |
107 | Hyperphosphaturia (HP:0003109) | 2.19783940 |
108 | Fused cervical vertebrae (HP:0002949) | 2.18890824 |
109 | Chorioretinal atrophy (HP:0000533) | 2.18702612 |
110 | * Pancreatitis (HP:0001733) | 2.18219044 |
111 | Abnormality of the labia minora (HP:0012880) | 2.17832398 |
112 | Congenital primary aphakia (HP:0007707) | 2.17603292 |
113 | Acute necrotizing encephalopathy (HP:0006965) | 2.16777570 |
114 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.15543528 |
115 | Chronic hepatic failure (HP:0100626) | 2.14860474 |
116 | Rhabdomyolysis (HP:0003201) | 2.13904937 |
117 | Cholecystitis (HP:0001082) | 2.13581220 |
118 | Abnormal gallbladder physiology (HP:0012438) | 2.13581220 |
119 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.13106230 |
120 | Late onset (HP:0003584) | 2.12837296 |
121 | Gait imbalance (HP:0002141) | 2.09185894 |
122 | Abnormal cartilage morphology (HP:0002763) | 2.09069317 |
123 | Hyperuricemia (HP:0002149) | 2.08605000 |
124 | Increased purine levels (HP:0004368) | 2.08605000 |
125 | Constricted visual fields (HP:0001133) | 2.08561418 |
126 | Vascular calcification (HP:0004934) | 2.08244091 |
127 | Short tibia (HP:0005736) | 2.08178227 |
128 | Renal cortical cysts (HP:0000803) | 2.08046937 |
129 | Hypertriglyceridemia (HP:0002155) | 2.07813275 |
130 | Hypothermia (HP:0002045) | 2.05935301 |
131 | Nephrogenic diabetes insipidus (HP:0009806) | 2.04627036 |
132 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04230867 |
133 | Abnormality of glycolysis (HP:0004366) | 2.03873073 |
134 | Increased serum pyruvate (HP:0003542) | 2.03873073 |
135 | Systemic lupus erythematosus (HP:0002725) | 2.03605813 |
136 | Bile duct proliferation (HP:0001408) | 2.02831338 |
137 | Abnormal biliary tract physiology (HP:0012439) | 2.02831338 |
138 | Opisthotonus (HP:0002179) | 2.02114800 |
139 | Abnormality of the renal cortex (HP:0011035) | 1.99828937 |
140 | Hyperglycemia (HP:0003074) | 1.99555928 |
141 | Postaxial hand polydactyly (HP:0001162) | 1.99297922 |
142 | Malnutrition (HP:0004395) | 1.97738944 |
143 | Sensorimotor neuropathy (HP:0007141) | 1.97216879 |
144 | Hydroxyprolinuria (HP:0003080) | 1.96394132 |
145 | Abnormality of proline metabolism (HP:0010907) | 1.96394132 |
146 | Increased muscle lipid content (HP:0009058) | 1.95625020 |
147 | Methylmalonic aciduria (HP:0012120) | 1.95591216 |
148 | Colon cancer (HP:0003003) | 1.93894431 |
149 | Glycosuria (HP:0003076) | 1.93557767 |
150 | Abnormality of urine glucose concentration (HP:0011016) | 1.93557767 |
151 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.92844314 |
152 | Type II lissencephaly (HP:0007260) | 1.92031931 |
153 | Esophageal varix (HP:0002040) | 1.91858930 |
154 | Genital tract atresia (HP:0001827) | 1.91538357 |
155 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91121288 |
156 | Morphological abnormality of the inner ear (HP:0011390) | 1.90822391 |
157 | Enlarged kidneys (HP:0000105) | 1.90107995 |
158 | Acute hepatic failure (HP:0006554) | 1.89856424 |
159 | Amyloidosis (HP:0011034) | 1.89025257 |
160 | Progressive macrocephaly (HP:0004481) | 1.87470625 |
161 | Postaxial foot polydactyly (HP:0001830) | 1.87210626 |
162 | Abnormality of renal resorption (HP:0011038) | 1.86094887 |
163 | Polydipsia (HP:0001959) | 1.85557836 |
164 | Abnormal drinking behavior (HP:0030082) | 1.85557836 |
165 | Cardiovascular calcification (HP:0011915) | 1.84635316 |
166 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.84208448 |
167 | Elevated hepatic transaminases (HP:0002910) | 1.83634678 |
168 | Acanthocytosis (HP:0001927) | 1.82805986 |
169 | Exertional dyspnea (HP:0002875) | 1.82735326 |
170 | Abnormality of the gallbladder (HP:0005264) | 1.82365883 |
171 | Glomerulonephritis (HP:0000099) | 1.82306829 |
172 | Vaginal atresia (HP:0000148) | 1.82280690 |
173 | Increased serum lactate (HP:0002151) | 1.81546798 |
174 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.81091605 |
175 | Sclerocornea (HP:0000647) | 1.77986347 |
176 | Pendular nystagmus (HP:0012043) | 1.73909193 |
177 | Menorrhagia (HP:0000132) | 1.73017009 |
178 | Supernumerary spleens (HP:0009799) | 1.72354999 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * BCKDK | 7.56009580 |
2 | SIK1 | 4.26174604 |
3 | ERN1 | 4.01752332 |
4 | INSRR | 3.52475613 |
5 | FGFR4 | 3.17872487 |
6 | BUB1 | 3.09269755 |
7 | PKN2 | 3.01968298 |
8 | MAP4K2 | 2.97137651 |
9 | TRIB3 | 2.90135929 |
10 | ZAK | 2.50705956 |
11 | STK39 | 2.48891777 |
12 | PDK3 | 2.45832799 |
13 | PDK4 | 2.45832799 |
14 | FLT3 | 2.33641403 |
15 | ERBB4 | 2.12829804 |
16 | PINK1 | 2.09058973 |
17 | PDK2 | 2.03807582 |
18 | NUAK1 | 1.93005645 |
19 | ADRBK2 | 1.91764499 |
20 | GRK1 | 1.88306204 |
21 | VRK2 | 1.87793625 |
22 | EIF2AK2 | 1.83926961 |
23 | MAP2K4 | 1.79178690 |
24 | TRIM28 | 1.76562450 |
25 | VRK1 | 1.74461170 |
26 | STK38L | 1.74317977 |
27 | MAPK11 | 1.73234599 |
28 | ERBB3 | 1.72781885 |
29 | NEK1 | 1.72283103 |
30 | BMPR1B | 1.65583659 |
31 | MAP3K4 | 1.62509605 |
32 | PIK3CG | 1.57056724 |
33 | MST1R | 1.56776768 |
34 | LATS1 | 1.56058448 |
35 | OXSR1 | 1.46673176 |
36 | CAMK1D | 1.45331192 |
37 | PRKAA2 | 1.34312696 |
38 | BCR | 1.30594577 |
39 | MKNK1 | 1.29679366 |
40 | BRSK2 | 1.28482435 |
41 | ABL2 | 1.27579132 |
42 | MET | 1.24070443 |
43 | TAOK3 | 1.22532666 |
44 | MAP2K7 | 1.22477523 |
45 | RPS6KA4 | 1.19160786 |
46 | MAPK13 | 1.18028049 |
47 | TNIK | 1.17043822 |
48 | KDR | 1.14872574 |
49 | CSNK1A1L | 1.07155357 |
50 | PLK4 | 1.05061808 |
51 | TIE1 | 1.04115352 |
52 | PRKCE | 0.99430423 |
53 | MAP3K7 | 0.96563152 |
54 | TXK | 0.93967492 |
55 | DYRK2 | 0.93615217 |
56 | SRPK1 | 0.92488111 |
57 | EPHA4 | 0.92228405 |
58 | MAP2K3 | 0.91879980 |
59 | PRKAA1 | 0.90097088 |
60 | TAF1 | 0.89702640 |
61 | PLK3 | 0.89691805 |
62 | PTK6 | 0.89640549 |
63 | NEK9 | 0.88159753 |
64 | MKNK2 | 0.88042700 |
65 | ATR | 0.86736642 |
66 | MAP3K3 | 0.86070469 |
67 | MAPK12 | 0.85976547 |
68 | CDC7 | 0.85682987 |
69 | LATS2 | 0.84405241 |
70 | TGFBR1 | 0.84376585 |
71 | MAP2K1 | 0.84143423 |
72 | TYK2 | 0.81317977 |
73 | JAK2 | 0.79745407 |
74 | PHKG1 | 0.78800807 |
75 | PHKG2 | 0.78800807 |
76 | MAPKAPK5 | 0.78524021 |
77 | IRAK3 | 0.77982034 |
78 | EIF2AK1 | 0.77210268 |
79 | MUSK | 0.76889223 |
80 | FRK | 0.75897856 |
81 | PRKACG | 0.75165138 |
82 | TGFBR2 | 0.74941086 |
83 | KIT | 0.73447856 |
84 | PRKCZ | 0.73087901 |
85 | FGFR2 | 0.72864090 |
86 | CASK | 0.72447062 |
87 | CSNK1G3 | 0.72027716 |
88 | MAP3K11 | 0.71513974 |
89 | CSNK1G2 | 0.70930185 |
90 | CAMK2G | 0.70188282 |
91 | OBSCN | 0.69297568 |
92 | MAPK15 | 0.68971164 |
93 | PDPK1 | 0.68147724 |
94 | MST4 | 0.66781364 |
95 | PLK1 | 0.66473580 |
96 | PAK3 | 0.64164164 |
97 | MAPK4 | 0.63745109 |
98 | RPS6KA5 | 0.63569536 |
99 | TEC | 0.63333655 |
100 | TLK1 | 0.62001467 |
101 | PRKCQ | 0.61926976 |
102 | CDK4 | 0.61734354 |
103 | NLK | 0.61281079 |
104 | LMTK2 | 0.60747383 |
105 | PLK2 | 0.60487441 |
106 | MAP2K2 | 0.60405926 |
107 | MAPK7 | 0.60240620 |
108 | CDK8 | 0.60036278 |
109 | MAPKAPK3 | 0.59801881 |
110 | EPHB2 | 0.59798832 |
111 | ABL1 | 0.59129421 |
112 | PRKCG | 0.58009139 |
113 | MYLK | 0.56750337 |
114 | MTOR | 0.56470396 |
115 | ERBB2 | 0.56296623 |
116 | INSR | 0.56227738 |
117 | TTN | 0.56118530 |
118 | GSK3A | 0.55789868 |
119 | MAP3K6 | 0.55596401 |
120 | PIK3CA | 0.54402826 |
121 | NME2 | 0.52552817 |
122 | CDK6 | 0.52263736 |
123 | NTRK2 | 0.52117044 |
124 | IRAK2 | 0.50679973 |
125 | CDK19 | 0.50602120 |
126 | DAPK2 | 0.49829097 |
127 | WEE1 | 0.49712299 |
128 | ICK | 0.48646829 |
129 | MAP2K6 | 0.48480228 |
130 | WNK3 | 0.48270696 |
131 | ATM | 0.47721167 |
132 | AURKA | 0.46624129 |
133 | MINK1 | 0.46129377 |
134 | CAMK2A | 0.45010573 |
135 | STK16 | 0.44589311 |
136 | PDK1 | 0.44258120 |
137 | CAMK1G | 0.43818488 |
138 | WNK4 | 0.43554320 |
139 | KSR2 | 0.41924616 |
140 | DYRK1B | 0.41502952 |
141 | CSNK1A1 | 0.40934073 |
142 | AURKB | 0.40569133 |
143 | CDK3 | 0.40248136 |
144 | CHUK | 0.39286708 |
145 | FER | 0.38375859 |
146 | EPHB1 | 0.37093362 |
147 | CSNK1D | 0.36528859 |
148 | TAOK2 | 0.36365380 |
149 | ADRBK1 | 0.35907504 |
150 | PRKD1 | 0.34587187 |
151 | EIF2AK3 | 0.34324993 |
152 | MAP3K10 | 0.33733373 |
153 | CSNK1G1 | 0.33457927 |
154 | ACVR1B | 0.32839874 |
155 | PBK | 0.32347671 |
156 | SGK2 | 0.32159383 |
157 | MAP3K5 | 0.31637295 |
158 | JAK1 | 0.30620502 |
159 | AKT2 | 0.29971288 |
160 | TTK | 0.28170269 |
161 | PRKACA | 0.26257141 |
162 | IGF1R | 0.26111028 |
163 | PRKACB | 0.25265352 |
164 | PTK2 | 0.23121988 |
165 | EPHA3 | 0.22744031 |
166 | RET | 0.22714113 |
167 | GRK6 | 0.22393121 |
168 | TBK1 | 0.21804922 |
169 | PKN1 | 0.20042085 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.86441636 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.26469818 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10135972 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95240276 |
5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.92236512 |
6 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.88474153 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81094548 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75300120 |
9 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.64274910 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62033105 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56514904 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48706455 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34944612 |
14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.27826358 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24171559 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20498755 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.09478990 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05592922 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02408712 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88840486 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83745997 |
22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.80209483 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77040945 |
24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.74292957 |
25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71806142 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70858936 |
27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68529066 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67944400 |
29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67884231 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64668704 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61313046 |
32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61094499 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59377694 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59072031 |
35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56517259 |
36 | Protein export_Homo sapiens_hsa03060 | 1.53038534 |
37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52532922 |
38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49460913 |
39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47424269 |
40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46991658 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46055825 |
42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44051766 |
43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40299463 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37013168 |
45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34440196 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27172939 |
47 | Phototransduction_Homo sapiens_hsa04744 | 1.25772105 |
48 | Bile secretion_Homo sapiens_hsa04976 | 1.25740394 |
49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25207158 |
50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23272155 |
51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.21171253 |
52 | Homologous recombination_Homo sapiens_hsa03440 | 1.14763765 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09827342 |
54 | Base excision repair_Homo sapiens_hsa03410 | 1.05359471 |
55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04849956 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04430984 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00846653 |
58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97965230 |
59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95412184 |
60 | Proteasome_Homo sapiens_hsa03050 | 0.93774855 |
61 | ABC transporters_Homo sapiens_hsa02010 | 0.93175225 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93081244 |
63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92447668 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92428931 |
65 | RNA polymerase_Homo sapiens_hsa03020 | 0.90507967 |
66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90265061 |
67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90118313 |
68 | RNA degradation_Homo sapiens_hsa03018 | 0.89351696 |
69 | Mismatch repair_Homo sapiens_hsa03430 | 0.88835002 |
70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88237457 |
71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86863028 |
72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84978657 |
73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84521374 |
74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78813106 |
75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78019558 |
76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76068844 |
77 | Lysine degradation_Homo sapiens_hsa00310 | 0.75031075 |
78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74830689 |
79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74206914 |
80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72995654 |
81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70780268 |
82 | Purine metabolism_Homo sapiens_hsa00230 | 0.69598847 |
83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69492408 |
84 | Ribosome_Homo sapiens_hsa03010 | 0.68863121 |
85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68597501 |
86 | Taste transduction_Homo sapiens_hsa04742 | 0.67050732 |
87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64327796 |
88 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63880466 |
89 | Salivary secretion_Homo sapiens_hsa04970 | 0.59606828 |
90 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56500904 |
91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55222747 |
92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52805675 |
93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51241295 |
94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47632642 |
95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44355610 |
96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.43753101 |
97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43455792 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42199763 |
99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38672674 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38511026 |
101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36472102 |
102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33840359 |
103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32243091 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.29529226 |
105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29183006 |
106 | Prion diseases_Homo sapiens_hsa05020 | 0.27701179 |
107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23372780 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23207779 |
109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22765508 |
110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.21743033 |
111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21365764 |
112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18468191 |
113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17291027 |
114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.03578945 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01760011 |
116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00396491 |
117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1976691 |
118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1958405 |
119 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1881324 |
120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1757604 |
121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1739252 |
122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1460539 |
123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1307174 |
124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1244244 |
125 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1223091 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1212300 |
127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1129360 |
128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0982620 |
129 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0942910 |
130 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0675544 |
131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0437485 |